| Specialty Retail Industry | Consumer Discretionary Sector | Mr. Prashant Rathi CEO | MSE Exchange | INE650L01011 ISIN |
| India Country | 293 Employees | - Last Dividend | 11 Feb 2020 Last Split | - IPO Date |
Brooks Laboratories Limited is a distinguished player in the pharmaceutical industry, known for its robust manufacturing and distribution capabilities. Established in 2002 and headquartered in Mumbai, India, the company has carved a niche for itself both on domestic and international fronts. Brooks Laboratories Limited specializes in the development, manufacture, and sale of a diverse range of pharmaceutical products, catering to various therapeutic areas and needs. Employing state-of-the-art manufacturing processes and adhering to stringent quality standards, the company ensures that its products are safe, effective, and of high quality. Through its dedication to excellence and innovation, Brooks Laboratories Limited continues to expand its footprint, striving to improve healthcare outcomes globally.
These products include sterile formulations intended for administration as injections. They cater to various medical conditions, offering both liquid and dry powder forms to suit different therapeutic needs and preferences of administration.
Part of Brooks Laboratories' product lineup includes carbapenem antibiotics, which are used to treat a wide range of serious bacterial infections. These drugs are known for their broad-spectrum activity against both gram-positive and gram-negative bacteria.
The company produces a variety of tablets designed to address a multitude of health conditions. Tablets are one of the most common pharmaceutical formulations, favored for their ease of consumption, dosage accuracy, and stability.
Dry syrup formulations are provided by Brooks Laboratories, which are essentially powder mixtures requiring reconstitution with water before use. This form is particularly useful for pediatric and geriatric patients who may have difficulty swallowing tablets or capsules.
Comprehensive care for ophthalmic and otic conditions is available through Brooks Laboratories' range of eye and ear drops. These products are formulated to deliver targeted relief and treatment for infections, allergies, and other disorders affecting the eyes and ears.